
Anlon Healthcare Ltd is Rated Hold by MarketsMOJO
2026-06-02 10:10:51Anlon Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 02 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Anlon Healthcare Ltd Quality Grade Upgraded to Average: A Detailed Fundamental Analysis
2026-06-02 08:01:16Anlon Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently seen its quality grade upgraded from 'Does Not Qualify' to 'Average' as of 1 June 2026. This shift reflects notable changes in the company’s business fundamentals, including profitability metrics, debt levels, and operational consistency. This article delves into the specifics of these improvements and areas where challenges remain, providing investors with a comprehensive view of Anlon Healthcare’s evolving financial health.
Read full news article
Anlon Healthcare Q4 FY26: Strong Profit Rebound Masks Margin Pressure and Valuation Concerns
2026-05-30 16:58:31Anlon Healthcare Ltd. delivered a robust profit recovery in Q4 FY26, posting consolidated net profit of ₹10.50 crores, marking a dramatic 103.88% sequential surge from the preceding quarter's ₹5.15 crores. The micro-cap pharmaceutical company, with a market capitalisation of ₹731.00 crores, demonstrated strong topline momentum as net sales climbed 43.03% quarter-on-quarter to ₹50.89 crores, though operating margins contracted to 30.05% from 34.49% in Q3 FY26. The stock closed at ₹13.59 on June 1, 2026, down 2.79% from the previous session, reflecting cautious investor sentiment despite the headline profit growth.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
30-May-2026 | Source : BSECopy of newspaper publication dated May 30 2026 regarding publication of extract of Audited Financial Results (Standalone and Consolidated) for Quarter and Year ended 31st March 2026.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
30-May-2026 | Source : BSEIntimation for Press Release of Audited Financial Results (Standalone and Consolidated) for the Quarter and Year ended March 31 2026.
Board Meeting Outcome for To Consider And Approve Financial Results For The Quarter And Year Ended March 31 2026
29-May-2026 | Source : BSEWe have attached herewith outcome of Board Meeting held on Friday May 29 2026. Kindly take the same on your record. Thank you.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Anlon Healthcare Ltd has announced 2:10 stock split, ex-date: 24 Apr 26
Anlon Healthcare Ltd has announced 1:1 bonus issue, ex-date: 24 Apr 26
No Rights history available






